BNP Paribas Financial Markets
KZIA

BNP Paribas Financial Markets’s Kazia Therapeutics KZIA Stock Holding History

BNP Paribas Financial Markets’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.04K Buy
+1,081
New +$7.53K ﹤0.01% 5254
2024
Q3 		– Sell
-1,271
Closed -$14.5K – 4194
2024
Q2 		$14.5K Buy
1,271
+299
+31% +$4.45K ﹤0.01% 3682
2024
Q1 		$15.1K Buy
972
+718
+283% +$10.8K ﹤0.01% 3665
2023
Q4 		$5.58K Buy
254
+84
+49% +$2.46K ﹤0.01% 3742
2023
Q3 		$8.46K Buy
170
+104
+158% +$5.08K ﹤0.01% 3637
2023
Q2 		$3.76K Buy
+66
New +$4.16K ﹤0.01% 3690

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets's KZIA Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Kazia Therapeutics (KZIA) in Q1 2026: 1,081 shares worth $8.04K. The stake represents ﹤0.01% of the portfolio and ranks #5254 among its holdings. This is a return to the name: BNP Paribas Financial Markets previously reported a position in KZIA as recently as Q2 2024.

BNP Paribas Financial Markets first reported a position in KZIA in Q2 2023 and has held it in 6 quarters since. The position peaked at $15.1K in Q1 2024. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • BNP Paribas Financial Markets held 1,081 shares of Kazia Therapeutics worth $8.04K as of Q1 2026.
  • Kazia Therapeutics was a new BNP Paribas Financial Markets position in Q1 2026.
  • Kazia Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5254 holding.
  • BNP Paribas Financial Markets first reported a position in Kazia Therapeutics in Q2 2023 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Kazia Therapeutics position peaked at $15.1K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.